Cargando…
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
IMPORTANCE: Despite controversy surrounding the 340B program, no study has analyzed trends in the proportion of Medicare Part D pharmacy claims eligible for 340B discounts. OBJECTIVE: To describe trends in the proportion of Medicare Part D claims that are prescribed by 340B-affiliated clinicians and...
Autores principales: | Dickson, Sean, Gabriel, Nico, Hernandez, Inmaculada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656642/ https://www.ncbi.nlm.nih.gov/pubmed/37976048 http://dx.doi.org/10.1001/jamahealthforum.2023.4091 |
Ejemplares similares
-
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016
por: Conti, Rena M., et al.
Publicado: (2019) -
Comparison of Generic Prescribing Patterns Among 340B-Eligible and Non-340B Prescribers in the Medicare Part D Program
por: Dickson, Sean, et al.
Publicado: (2023) -
Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019
por: Dickson, Sean, et al.
Publicado: (2023) -
Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019
por: Dickson, Sean R., et al.
Publicado: (2023) -
Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals
por: Li, Yufei, et al.
Publicado: (2022)